Condition: Small-cell Lung Cancer · Extensive Stage Small-cell Lung Cancer · Sponsor: Amgen
The main objective of the study is to compare the efficacy of tarlatamab in combination with durvalumab, carboplatin and etoposide to the combination of durvalumab, carboplatin and etoposide on prolonging overall survival (OS).
This description comes directly from the study's public registry record.
Amgen Call Center · 866-572-6436 · medinfo@amgen.com
Always discuss trial participation with your own doctor first.
| Cancer and Blood Specialists of Arizona | Casa Grande, Arizona, United States | Recruiting |
| City of Hope Cancer Center Phoenix | Goodyear, Arizona, United States | Recruiting |
| Genesis Cancer Center | Hot Springs, Arkansas, United States | Recruiting |
| Saint Bernards Medical Center | Jonesboro, Arkansas, United States | Recruiting |
| Providence Saint Jude Medical Center | Fullerton, California, United States | Recruiting |
| Translational Research in Oncology US Inc, Trio Central Pharmacy | Los Angeles, California, United States | Recruiting |
| University of California Los Angeles | Santa Monica, California, United States | Recruiting |
| Presbyterian Intercommunity Hospital Health Whitter Hospital | Whittier, California, United States | Recruiting |
| Colorado West Healthcare System dba Grand Valley Oncology | Grand Junction, Colorado, United States | Recruiting |
| Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut | New Britain, Connecticut, United States | Recruiting |
| Yale New Haven Hospital | New Haven, Connecticut, United States | Recruiting |
| Eastern Connecticut Hematology and Oncology Associates | Norwich, Connecticut, United States | Recruiting |
+ 152 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07005128